BCR and acute kidney injury: Highly expressed EPOR/βcR in damaged cells provides a great opportunity for cell target delivery of drugs that was conjugated with its ligand such as siRNA conjugated with HBSP to precisely treat IR-induced AKI, promote repair/remodeling, and prevent its chronic progression to fibrosis.